Results for tag: "Limb Girdle Muscular Dystrophy Drug"

Limb Girdle Muscular Dystrophy (LGMD) is a group of inherited muscle diseases that cause progressive weakness and wasting of the muscles of the hips, shoulders, and upper arms. Musculoskeletal Disorders Drugs are used to treat LGMD and other muscular dystrophies. These drugs are designed to slow the progression of the disease, improve muscle strength, and reduce pain. Commonly used drugs include corticosteroids, immunosuppressants, and enzyme replacement therapies. The Limb Girdle Muscular Dystrophy Drug market is a rapidly growing segment of the Musculoskeletal Disorders Drugs market. Companies in this market are focused on developing treatments for LGMD and other muscular dystrophies. These companies include Sarepta Therapeutics, Pfizer, Novartis, and F. Hoffmann-La Roche. Show Less Read more